In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews (7/01)

Executive Summary

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups focus on Biorepositories (Asterand Inc., BioSample Inc., Genomics Collaborative Inc., TissueInformatics Inc.); Therapeutics for Diabetes and Obesity (Arexis AB, Diabetogen Biosciences Inc., PanCel Corp., Rademacher Group Ltd.); and Orthopedic and Surgical Devices (Ascension Orthopedics Inc., Coapt Systems Inc., NuVasive Inc., SpringFlex Orthopedics Inc.). Plus these Selected Start-Ups across Health Care: Achillion Pharmaceuticals Inc., GeneProt Inc., MonitorForHire.com and Targacept Inc.

You may also be interested in...



The Global Generics & Biosimilars Awards 2020 Is Going Digital

The Global Generics & Biosimilars Awards 2020 will take place on 3 November as a digital event, with a newly-extended entry deadline date of 14 August.

Coronavirus Update: Japan's Supercomputer Joins COVID-19 Drug Hunt

Developed by Japan’s national research institute, the supercomputer has been tasked with characterizing the SARS-CoV-2 virus, identifying therapeutic molecules, modeling infection spread and socio-economic impact.

Pipeline Watch: First Approvals For Vadadustat, Daprodustat, In Japan

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Related Companies

UsernamePublicRestriction

Register

SC142018

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel